Mr. Fair has over 25 years of senior executive management and entrepreneurial experience focused in medical device and biologic platforms. Mr. Fair’s operational experience covers areas such as strategic market plans, product development, sales, marketing, finance and the ability to take platform technologies from creation through commercialization in the most efficient pathway possible.
Mr. Fair began his medical device career at DePuy, where alongside a small team of personnel, helped to build the spine franchise from a $10M business to a $350M business within a 9 year timeframe. Mr. Fair then served as Vice President Sales & Marketing, St. Francis Medical Technologies where he was responsible for the US launch of the XSTOP device. The launch of the XSTOP achieved $43M in US revenue in the first 11 months and resulted in the largest medical device multiple with an acquisition price of $725M to Kyphon. After St. Francis, Mr. Fair served as the COO of MedShape Solutions, an innovative shape memory polymer and nitinol company, where he remains an active investor. Mr. Fair went on to start Amniox Medical, a spin out company based on amniotic tissue therapies for markets outside of ophthalmology. In the company’s first year of operation, Amniox surpassed all revenue targets and achieved profitability. Most recently, Mr. Fair served as President & CEO of a private equity backed spine venture, Amendia/Spinal Elements, a $100M + spinal implant company based in Carlsbad, CA.
Mr. Fair serves on the boards of Spinal Elements, CellectCell, and 510Kardiac.
Mr. Fair received his BS Business Administration from the University of Richmond.